N@N

ALXA, CWCO, PSMT, DPTR, ANPI, ACAD Expected To Be Down After Next Earnings Releases

^{Published on 2010-11-08 07:05:09, Last Modified on 2010-12-22 19:19:07 - WOPRAI}
 

November 8, 2010 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, November 9th 2010 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and November earnings reports. ALEXZA PHARMACEUTICALS INC (NASDAQ:ALXA), CONSOLIDATED WATER CO-ORD SH (NASDAQ:CWCO), PRICESMART INC (NASDAQ:PSMT), DELTA PETROLEUM CORP (NASDAQ:DPTR), ANGIOTECH PHARMACEUTICALS IN (NASDAQ:ANPI), ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) are all expected to be Down After their earnings are released Tuesday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Tuesday:

     Symbol     Company                         # of Reports            Quarter     Release Time
     ALXA       ALEXZA PHARMACEUTICALS INC      12 Quarter              Q3           After
     CWCO       CONSOLIDATED WATER CO-ORD SH     12 Quarter              Q3           After
     PSMT       PRICESMART INC                  November Earnings       Q4           Before
     DPTR       DELTA PETROLEUM CORP            12 Quarter              Q3           Before
     ANPI       ANGIOTECH PHARMACEUTICALS IN     12 Quarter              Q3           Before
     ACAD       ACADIA PHARMACEUTICALS INC      12 Quarter              Q3           After

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

ALEXZA PHARMACEUTICALS INC (NASDAQ:ALXA) - Alexza Pharmaceuticals, Inc., a development stage company, focuses on the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are based on a proprietary technology, the Staccato system that vaporizes an excipient-free drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. The companys clinical-stage product candidates comprise AZ-004 (staccato loxapine), which is licensed to Biovail Laboratories International SRL for the acute treatment of agitation in patients with schizophrenia or bipolar disorder; AZ-007 (staccato zaleplon), which completed phase I status for the treatment of insomnia; and AZ-001 (staccato prochlorperazine) and AZ-104 (staccato loxapine, low-dose), phase II product candidates for the treatment of migraine headache. It also develops AZ-002 (Staccato alprazolam), which completed a phase 1 clinical trial in healthy subjects and a phase 2a proof-of-concept clinical trial in panic disorder patients for the treatment of panic attacks; and AZ-003 (Staccato fentanyl) that completed phase 1 clinical trial for the treatment of patients with acute pain, including patients with breakthrough cancer pain and postoperative patients with acute pain episodes. The company was formerly known as Alexza Molecular Delivery Corporation and changed its name to Alexza Pharmaceuticals, Inc. in July 2005. Alexza Pharmaceuticals, Inc. was founded in 2000 and is based in Mountain View, California.

CONSOLIDATED WATER CO-ORD SH (NASDAQ:CWCO) - Consolidated Water Co. Ltd. and its subsidiaries develop and operate seawater desalination plants and water distribution systems, as well as produce and supply water to customers in the Cayman Islands, the Bahamas, Belize, the British Virgin Islands, and Bermuda. It uses reverse osmosis technology to convert seawater to potable water. The company supplies water to end-users, including residential, commercial, and government customers. As of December 31, 2009, Consolidated Water Co. operated 16 reverse osmosis desalination plants through its subsidiaries and affiliates. It also offers engineering and management services, including designing and constructing desalination plants, and managing and operating desalination plants owned by other companies. The company was founded in 1973 and is based in Grand Cayman, Cayman Islands.

PRICESMART INC (NASDAQ:PSMT) - PriceSmart, Inc. owns and operates warehouse clubs in Central America and the Caribbean. Its warehouse clubs sell consumer goods and perishable foods at low prices to individuals and businesses, as well as offers ancillary services, which include food courts, tire centers, and photo centers. As of May 7, 2010, it operated 27 warehouse clubs in 11 countries and 1 U.S. territory, including 5 in Costa Rica; 4 each in Panama and Trinidad; 3 in Guatemala; 2 each in Dominican Republic, El Salvador, and Honduras; and 1 each in Aruba, Barbados, Jamaica, Nicaragua, and the United States Virgin Islands. The company was founded in 1994 and is headquartered in San Diego, California.

DELTA PETROLEUM CORP (NASDAQ:DPTR) - Delta Petroleum Corporation and its subsidiaries engage in the exploration, acquisition, development, production, and sale of natural gas and crude oil primarily in the Rocky Mountain and onshore Gulf Coast regions. The company owns interests in developed and undeveloped oil and gas properties in federal units offshore California, near Santa Barbara; and developed and undeveloped oil and gas properties in the continental United States. It also engages in contract drilling operations, as well as providing moving services for third party drilling rigs in the Casper, Wyoming area. As of December 31, 2009, the companys proved reserves were comprised of approximately 126.7 billion cubic feet of natural gas, and 4.5 Mmbbls of crude oil. Delta Petroleum Corporation was founded in 1984 and is based in Denver, Colorado.

ANGIOTECH PHARMACEUTICALS IN (NASDAQ:ANPI) - Angiotech Pharmaceuticals, Inc. discovers, develops, and markets technologies focused on acute and surgical applications in the United States and internationally. The companys Medical Products segment offers a range of single-use specialty medical products and medical device components. Its products include Quill SRS, a surface modified suture material; SKATER drainage catheter to facilitate drainage of fluid from wounds, infectious tissues, or surgical sites; Option Inferior vena cava (IVC) filters; HemoStream dialysis catheter for short-term vascular access of patients with kidney disease; BioPince biopsy instrument to obtain tissue samples from patients for analysis and diagnosis of disease; and 5-flourouracil (5-FU) technology to be combined with selected implantable medical devices in order to reduce infection. This segment also offers disposable and re-usable soft tissue biopsy products for use in breast, lung, spinal, and bone marrow biopsies; a range of surgical blades that are used primarily in cataract or other ophthalmic surgery; surgical wound closure products; and medical device components for other medical device manufacturers. Its Pharmaceutical Technologies segment licenses its proprietary paclitaxel and other technologies to medical device, pharmaceutical, and biomaterials companies. This segment offers TAXUS Express, TAXUS Liberte, and TAXUS Element coronary stent systems for the treatment of restenosis; and CoSeal surgical sealant to seal tissue surfaces and synthetic grafts. The companys clinical programs include MultiStem stem cell therapy for myocardial infarction; and 5-FU-Eluting anti-infective central venous catheter to prevent catheter related infections. In addition, it is developing fibrin sealant and thrombin hemostat, which are human biomaterial product candidates. Angiotech Pharmaceuticals was founded in 1989 and is headquartered in Vancouver, Canada.

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) - ACADIA Pharmaceuticals, Inc., a biopharmaceutical company, focuses on drug discovery and clinical development of novel treatments for central nervous system disorders. The company is developing a portfolio of four product candidates, including pimavanserin, which is being developed for three separate neurological and psychiatric indications in collaboration with Biovail. These indications include Parkinsons disease psychosis that is in Phase III development; adjunctive therapy for schizophrenia, which is in Phase III planning; and Alzheimers disease psychosis, for which ACADIA is planning to initiate a Phase II feasibility study. The company also has other products under development, including a product candidate in Phase II development for chronic pain; and a product candidate in Phase I development for glaucoma, both in collaboration with Allergan, as well as a program in IND-track development in collaboration with Meiji Seika Kaisha. The products in ACADIAs pipeline emanate from discoveries made using its proprietary drug discovery platform. The company, formerly known as Receptor Technologies, Inc., was founded in 1993 and is headquartered in San Diego, California.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641